MDGL
MDGL
US5588681057
Madrigal Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
10.9B EUR
12.4B EUR
12.06B EUR
13.3B EUR
Enterprise Value
10.53B EUR
12.46B EUR
12.18B EUR
13.45B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
49.01x
--
--
--
Price to Sales
8.49x
9.66x
10.65x
16.2x
Price to Book
20.8x
23.68x
22.19x
22.07x
EV/Revenue
8.2x
9.7x
10.76x
16.38x
EV/EBITDA
-32.79x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-0.74%
-1.69%
-2.28%
-0.78%
ende